Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    24255071 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy Study of ABR-215050 to Treat Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: ABR-215050, tasquinimod;   Drug: Placebo

Indicates status has not been verified in more than two years